StockNews.com Upgrades Relx (NYSE:RELX) to Buy

StockNews.com upgraded shares of Relx (NYSE:RELX) from a hold rating to a buy rating in a research report released on Friday morning.

Separately, Redburn Atlantic initiated coverage on shares of Relx in a research report on Wednesday, January 8th. They set a “buy” rating for the company.

Relx Trading Down 1.5 %

Shares of NYSE:RELX opened at $51.14 on Friday. The company has a quick ratio of 0.42, a current ratio of 0.48 and a debt-to-equity ratio of 1.63. Relx has a fifty-two week low of $40.25 and a fifty-two week high of $51.99. The firm has a 50-day simple moving average of $47.74 and a 200 day simple moving average of $47.13.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently bought and sold shares of the company. Lido Advisors LLC grew its position in Relx by 30.5% in the 4th quarter. Lido Advisors LLC now owns 16,919 shares of the technology company’s stock worth $768,000 after purchasing an additional 3,958 shares during the last quarter. Northern Trust Corp grew its position in Relx by 51.6% in the 4th quarter. Northern Trust Corp now owns 2,191,588 shares of the technology company’s stock worth $99,542,000 after purchasing an additional 745,532 shares during the last quarter. Aquatic Capital Management LLC bought a new position in Relx in the 4th quarter worth about $1,998,000. Kovitz Investment Group Partners LLC grew its position in Relx by 3.4% in the 4th quarter. Kovitz Investment Group Partners LLC now owns 8,159 shares of the technology company’s stock worth $371,000 after purchasing an additional 267 shares during the last quarter. Finally, Syon Capital LLC grew its position in Relx by 4.5% in the 4th quarter. Syon Capital LLC now owns 12,070 shares of the technology company’s stock worth $548,000 after purchasing an additional 523 shares during the last quarter. Institutional investors own 15.02% of the company’s stock.

Relx Company Profile

RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.